Evolution of classification of thymic epithelial tumors in the era of Dr Thomas V. Colby

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Context.-Numerous histomorphologic and staging classifications of thymic epithelial tumors (TETs) have been proposed during the last century, suggesting that the classification of these tumors is challenging and controversial. Difficulties of classifying TETs include various combinations of epithelial cells and lymphocytes and the paucity of these tumors. The prognostic significance, specifically of the histomorphologic classifications, has been debated. Early classifications were also challenged by the uncertainty of the neoplastic component(s) of the tumor. Objective.-To discuss the evolution of the histomorphologic classification and the staging system of TET. Controversies and problems of some classifications and their importance for therapeutic management and prognosis will be reviewed. Classifications that incorporated new concepts and approaches at the time or outcome studies will be highlighted. Current classifications will be discussed and the staging system that was recently proposed for the upcoming eighth American Joint Committee on Cancer staging will be described. Data Sources.-Search of literature database (PubMed) and current (2015) World Health Organization classification. Conclusions.-Histomorphologic and staging classifications of TET have evolved during the last century and especially during the era of Thomas V. Colby, MD. Evidence supports that the staging system has prognostic implications independent of and superior to the histomorphologic classification. Histomorphology appears to be important for biologic features of TET.

Original languageEnglish (US)
Pages (from-to)232-246
Number of pages15
JournalArchives of Pathology and Laboratory Medicine
Volume141
Issue number2
DOIs
StatePublished - Feb 1 2017

Fingerprint

Thymic epithelial tumor
Neoplasms
Time and Motion Studies
Neoplasm Staging
Information Storage and Retrieval
PubMed
Uncertainty
Epithelial Cells
Outcome Assessment (Health Care)
Databases
Lymphocytes
Therapeutics

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Cite this

Evolution of classification of thymic epithelial tumors in the era of Dr Thomas V. Colby. / Roden, Anja.

In: Archives of Pathology and Laboratory Medicine, Vol. 141, No. 2, 01.02.2017, p. 232-246.

Research output: Contribution to journalArticle

@article{3211aa1e3a0c41699251299f9a25eb86,
title = "Evolution of classification of thymic epithelial tumors in the era of Dr Thomas V. Colby",
abstract = "Context.-Numerous histomorphologic and staging classifications of thymic epithelial tumors (TETs) have been proposed during the last century, suggesting that the classification of these tumors is challenging and controversial. Difficulties of classifying TETs include various combinations of epithelial cells and lymphocytes and the paucity of these tumors. The prognostic significance, specifically of the histomorphologic classifications, has been debated. Early classifications were also challenged by the uncertainty of the neoplastic component(s) of the tumor. Objective.-To discuss the evolution of the histomorphologic classification and the staging system of TET. Controversies and problems of some classifications and their importance for therapeutic management and prognosis will be reviewed. Classifications that incorporated new concepts and approaches at the time or outcome studies will be highlighted. Current classifications will be discussed and the staging system that was recently proposed for the upcoming eighth American Joint Committee on Cancer staging will be described. Data Sources.-Search of literature database (PubMed) and current (2015) World Health Organization classification. Conclusions.-Histomorphologic and staging classifications of TET have evolved during the last century and especially during the era of Thomas V. Colby, MD. Evidence supports that the staging system has prognostic implications independent of and superior to the histomorphologic classification. Histomorphology appears to be important for biologic features of TET.",
author = "Anja Roden",
year = "2017",
month = "2",
day = "1",
doi = "10.5858/arpa.2016-0057-RA",
language = "English (US)",
volume = "141",
pages = "232--246",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "2",

}

TY - JOUR

T1 - Evolution of classification of thymic epithelial tumors in the era of Dr Thomas V. Colby

AU - Roden, Anja

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Context.-Numerous histomorphologic and staging classifications of thymic epithelial tumors (TETs) have been proposed during the last century, suggesting that the classification of these tumors is challenging and controversial. Difficulties of classifying TETs include various combinations of epithelial cells and lymphocytes and the paucity of these tumors. The prognostic significance, specifically of the histomorphologic classifications, has been debated. Early classifications were also challenged by the uncertainty of the neoplastic component(s) of the tumor. Objective.-To discuss the evolution of the histomorphologic classification and the staging system of TET. Controversies and problems of some classifications and their importance for therapeutic management and prognosis will be reviewed. Classifications that incorporated new concepts and approaches at the time or outcome studies will be highlighted. Current classifications will be discussed and the staging system that was recently proposed for the upcoming eighth American Joint Committee on Cancer staging will be described. Data Sources.-Search of literature database (PubMed) and current (2015) World Health Organization classification. Conclusions.-Histomorphologic and staging classifications of TET have evolved during the last century and especially during the era of Thomas V. Colby, MD. Evidence supports that the staging system has prognostic implications independent of and superior to the histomorphologic classification. Histomorphology appears to be important for biologic features of TET.

AB - Context.-Numerous histomorphologic and staging classifications of thymic epithelial tumors (TETs) have been proposed during the last century, suggesting that the classification of these tumors is challenging and controversial. Difficulties of classifying TETs include various combinations of epithelial cells and lymphocytes and the paucity of these tumors. The prognostic significance, specifically of the histomorphologic classifications, has been debated. Early classifications were also challenged by the uncertainty of the neoplastic component(s) of the tumor. Objective.-To discuss the evolution of the histomorphologic classification and the staging system of TET. Controversies and problems of some classifications and their importance for therapeutic management and prognosis will be reviewed. Classifications that incorporated new concepts and approaches at the time or outcome studies will be highlighted. Current classifications will be discussed and the staging system that was recently proposed for the upcoming eighth American Joint Committee on Cancer staging will be described. Data Sources.-Search of literature database (PubMed) and current (2015) World Health Organization classification. Conclusions.-Histomorphologic and staging classifications of TET have evolved during the last century and especially during the era of Thomas V. Colby, MD. Evidence supports that the staging system has prognostic implications independent of and superior to the histomorphologic classification. Histomorphology appears to be important for biologic features of TET.

UR - http://www.scopus.com/inward/record.url?scp=85011700170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011700170&partnerID=8YFLogxK

U2 - 10.5858/arpa.2016-0057-RA

DO - 10.5858/arpa.2016-0057-RA

M3 - Article

C2 - 28134578

AN - SCOPUS:85011700170

VL - 141

SP - 232

EP - 246

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 2

ER -